Is the SEC Cracking Down on Life Science Companies Misleading Investors?
On December 3, the U.S. Securities and Exchange Commission settled charges against biotherapeutics company Kiromic BioPharma, Inc., its...
Is the SEC Cracking Down on Life Science Companies Misleading Investors?
On December 3, the U.S. Securities and Exchange Commission settled charges against biotherapeutics company Kiromic BioPharma, Inc., its...